BioAge Labs, Inc.
BIOA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709941
No open-market purchases or sales by BioAge Labs, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in BioAge Labs, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +20 vs. Q3 2025
- Shares held
- 23.7M
- +2.40M (+11.3%) vs. Q3 2025
- Total value
- $314.1M
- +$189.1M (+151.3%) vs. Q3 2025
- New holders
- 29
- 41 more added
- Sold out
- 9
- 23 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $924.6M |
| Q1 2026 | 144 | $599.2M |
| Q4 2025 | 114 | $314.1M |
| Q3 2025 | 94 | $125.0M |
| Q2 2025 | 83 | $85.6M |
| Q1 2025 | 67 | $76.2M |
| Q4 2024 | 65 | $113.7M |
| Q3 2024 | 58 | $430.8M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding BioAge Labs, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 409,207 | $5.41M | 0.00% | +409,207 | New |
| State Street Corp | 422,846 | $5.59M | 0.00% | +224,735+113.4% | Added |
| Cosmic Management, LLC | 501,833 | $6.64M | 2.05% | +501,833 | New |
| Geode Capital Management, LLC | 591,377 | $7.83M | 0.00% | +28,646+5.1% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 653,374 | $8.64M | 3.34% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 786,353 | $10.4M | 2.01% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 790,901 | $10.5M | 0.21% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $13.9M | 0.02% | +1,050,000 | New |
| Vanguard Group Inc | 1,414,770 | $18.7M | 0.00% | −236,477−14.3% | Reduced |
| BlackRock, Inc. | 1,527,541 | $20.2M | 0.00% | +247,920+19.4% | Added |
| Octagon Capital Advisors LP | 1,598,000 | $21.1M | 2.65% | +1,598,000 | New |
| Cormorant Asset Management, LP | 2,040,605 | $27.0M | 1.53% | −100,000−4.7% | Reduced |
| Sofinnova Investments, Inc. | 2,293,788 | $30.3M | 1.31% | 00.0% | Unchanged |
| AH Capital Management, L.L.C. | 3,233,170 | $44.1M | 2.79% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,600,000−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −382,406−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −37,193−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −30,723−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −184−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |